INITIAL AND LONG-TERM OUTPATIENT EXPERIENCE WITH LORCAINIDE FOR SUPPRESSION OF MALIGNANT AND POTENTIALLY MALIGNANT VENTRICULAR ARRHYTHMIAS

被引：5

作者：

ANASTASIOUNANA, MI ^{[1
]}

ANDERSON, JL ^{[1
]}

HAMPTON, EM ^{[1
]}

NANAS, JN ^{[1
]}

LUTZ, JR ^{[1
]}

机构：

[1] UNIV UTAH,LATTER DAY ST HOSP,SCH MED,DEPT MED,DIV CARDIOL,8TH AVE & C ST,SALT LAKE CITY,UT 84143

来源：

AMERICAN HEART JOURNAL | 1985年 / 110卷 / 06期

关键词：

D O I：

10.1016/0002-8703(85)90007-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1168 / 1175

页数：8

共 26 条

[11] RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED CROSSOVER TRIAL DOCUMENTING ORAL LORCAINIDE EFFICACY IN SUPPRESSION OF SYMPTOMATIC VENTRICULAR TACHYARRHYTHMIAS [J].

KEEFE, DL ;

PETERS, F ;

WINKLE, RA .

AMERICAN HEART JOURNAL, 1982, 103 (04) :511-518

[12]

KEEFE DL, 1984, AM J CARDIOL, V54, pB18

[13]

KESTELOOT H, 1977, ARCH INT PHARMACOD T, V230, P225

[14] LORCAINIDE INFUSION IN THE TREATMENT OF VENTRICULAR PREMATURE BEATS (VPB) [J].

KLOTZ, U ;

MULLERSEYDLITZ, PM ;

HEIMBURG, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) :1-6

[15]

MEINERTZ T, 1979, CLIN PHARM THER, V26, P187

[16]

PODRID PJ, 1984, AM J CARDIOL, V54, pB29

[17]

RUBERMAN W, 1977, NEW ENGL J MED, V297, P750, DOI 10.1056/NEJM197710062971404

[18] CLINICAL AND ELECTROPHYSIOLOGIC EFFECTS OF CHRONIC LORCAINIDE THERAPY IN REFRACTORY VENTRICULAR-TACHYCARDIA [J].

SAKSENA, S ;

ROTHBART, ST ;

CAPPELLO, G ;

BERNSTEIN, A ;

SOMANI, P .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (03) :538-544

[19]

SINGH SN, 1984, AM J CARDIOL, V54, pB22

[20] PHARMACOKINETICS OF LORCAINIDE, A NEW ANTI-ARRHYTHMIC DRUG, IN PATIENTS WITH CARDIAC-RHYTHM DISORDERS [J].

SOMANI, P .

AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (01) :157-163

← 1 2 3 →